Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Oncology department celebrates 50 years of excellence

2017-09-07

The UFS Department of Oncology celebrated 50 years of
existence. Prof Louis Goedhals says that the department
is like a family that will carry and support you.
Photo: Wendy Ruth

South Africa could see an increase of 78% in the number of cancer cases by 2030 and from a global perspective, a 75% increase is expected, increasing the total incidence of all new cancer cases from 12.7 million in 2008 to 22.2 million by 2030, according to a recent study published by medical journal Lancet. According to the Cancer Association of South Africa (CANSA), more than 100 000 South Africans are diagnosed each year. It is rather comforting that the University of the Free State’s (UFS) Faculty of Health Sciences has an Oncology department that has been fighting cancer for 50 years.

Excellence over the decades
The 50-year celebration of the Department of Oncology took place at the UFS Centenary Complex on the Bloemfontein Campus on 19 August 2017. The auspicious event was attended by UFS Faculty of Health Sciences registrars, radiation oncology radiographers and professional nurses who had trained in the department over the past 50 years, as well as the current departmental staff.

Dr Alicia Sherriff, Head of the Department of Oncology welcomed the dignitaries and thanked everyone for their attendance and dedication to the department, Prof Louis Goedhals, the oldest surviving head of department, gave a summary of the 50 years. He said once you were involved with this department you became part of a family that would carry and support you. Memories were shared and friendships rekindled. The message of this department that stood the test of time was: “To cure sometimes, to relieve often, to comfort always … and to bring hope”.

UFS dignitaries reveled in the moment
Among the special guests were the Rector and Vice Chancellor, Prof Francis Petersen, Prof Gert van Zyl, Dean of Faculty of Health Sciences; the Free State MEC for Health Mr Butana Komphela, and CEO of Universitas Hospital Dr Marcus Molokomme, were invited. The function was well attended by personnel, graduates from as far as Portugal, and dignitaries from the university. There was a sense of unity and belonging among all the attendees and enthusiastic catching up over the years that have passed.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept